Concepedia

Faris Albayya

FA

Statistics

Publications

21

Citations

1.2K

H-Index

18

Active since

1997

Affiliations

University of Michigan(Current)

Blueprint Medicines (United States)

National Cancer Center Hospital East

Dana-Farber Cancer Institute

Yonsei University

Faris Albayya is an author at University of Michigan specializing in life sciences, molecular biology, and calcium signaling.

ORCID

Publications per year

1997–2024

21

Publications

21

Discovery of BLU-945, a Reversible, Potent, and Wild-Type-Sparing Next-Generation EGFR Mutant Inhibitor for Treatment-Resistant Non-Small-Cell Lung Cancer

Meredith S. Eno, Jason D. Brubaker, John E. Campbell et al. · Journal of Medicinal Chemistry · 2022 · 160 citations · Full text

, , +14

Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy–associated mutant troponin T proteins

Elizabeth M. Rust, Faris Albayya, Joseph M. Metzger · Journal of Clinical Investigation · 1999 · 109 citations · Full text

, , +13

Direct, convergent hypersensitivity of calcium-activated force generation produced by hypertrophic cardiomyopathy mutant α-tropomyosins in adult cardiac myocytes

Daniel E. Michele, Faris Albayya, Joseph M. Metzger · Nature Medicine · 1999 · 90 citations

, , +16

In vivo acceleration of heart relaxation performance by parvalbumin gene delivery

Michael L. Szatkowski, Margaret V. Westfall, Carlen A. Gomez et al. · Journal of Clinical Investigation · 2001 · 90 citations · Full text

, , +16

Effects of Myosin Heavy Chain Isoform Switching on Ca <sup>2+</sup> -Activated Tension Development in Single Adult Cardiac Myocytes

Joseph M. Metzger, Philip A. Wahr, Daniel E. Michele et al. · Circulation Research · 1999 · 84 citations · Full text

, , +16

1–5 of 21